Evotec SE (EVO) Capital Leases (2009 - 2010)

Evotec SE (EVO) reported Capital Leases of $61.98 for Q3 2010, down 32.47% sequentially from $91.79 in Q2 2010.

Evotec SE (EVO) Capital Leases (2009 - 2010) Analysis & Trends

Evotec SE (EVO) has 2 years of Capital Leases data on file, last reported at $61.98 in Q3 2010.

For the quarter ending Q3 2010, Capital Leases changed N/A year-over-year to $61.98; the trailing twelve-month figure through Sep 2010 stood at $61.98 (changed N/A YoY), and the FY2009 full-year result was $184.13, changed N/A from the prior year.
Capital Leases eased to $61.98 in Q3 2010, from $91.79 in the prior quarter.
In the past five years, Capital Leases ranged from a high of $359626.7 in Q1 2009 to a low of $61.98 in Q3 2010.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Evotec SE	351.60 Mn	351.08 Mn	-

Historic Data

Download Data

Date	Value
Sep 30, 2010	61.98
Jun 30, 2010	91.79
Mar 31, 2010	149.55
Dec 31, 2009	194.93
Jun 30, 2009	276,414.61
Mar 31, 2009	359,626.73